EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.1.4.39 | Atherosclerosis |
11861673 |
Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits. |
causal interaction
unassigned |
1
0 |
| 3.1.4.39 | Atherosclerosis |
12069806 |
Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. |
causal interaction
diagnostic usage
unassigned |
4
1
0 |
| 3.1.4.39 | Atherosclerosis |
33017574 |
Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
1
4
0 |
| 3.1.4.39 | Autoimmune Diseases |
31231367 |
LPA5 Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 3.1.4.39 | Blister |
16117781 |
Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity. |
ongoing research
unassigned |
2
0 |
| 3.1.4.39 | Breast Neoplasms |
16601922 |
Identification of large-scale molecular changes of Autotaxin(ENPP2) knock-down by small interfering RNA in breast cancer cells. |
causal interaction
ongoing research
unassigned |
1
3
0 |
| 3.1.4.39 | Breast Neoplasms |
26065921 |
Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1. |
causal interaction
unassigned |
1
0 |
| 3.1.4.39 | Breast Neoplasms |
28539367 |
Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 3.1.4.39 | Breast Neoplasms |
30567518 |
ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro. |
causal interaction
unassigned |
4
0 |
| 3.1.4.39 | Carcinogenesis |
19222837 |
Novel point mutations attenuate autotaxin activity. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
